Cargando…
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials
BACKGROUND: Two radiotherapy fractionation schedules are used to treat locally advanced bladder cancer: 64 Gy in 32 fractions over 6·5 weeks and a hypofractionated schedule of 55 Gy in 20 fractions over 4 weeks. Long-term outcomes of these schedules in several cohort studies and case series suggest...
Autores principales: | Choudhury, Ananya, Porta, Nuria, Hall, Emma, Song, Yee Pei, Owen, Ruth, MacKay, Ranald, West, Catharine M L, Lewis, Rebecca, Hussain, Syed A, James, Nicholas D, Huddart, Robert, Hoskin, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851111/ https://www.ncbi.nlm.nih.gov/pubmed/33539743 http://dx.doi.org/10.1016/S1470-2045(20)30607-0 |
Ejemplares similares
-
The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)
por: Choudhury, Ananya, et al.
Publicado: (2017) -
Hypofractionation: less is more?
por: Mariam, Neethu Billy Graham, et al.
Publicado: (2021) -
Dynamic prediction methods in the BC2001 clinical trial
por: Porta, Nuria, et al.
Publicado: (2015) -
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer
por: Portner, R., et al.
Publicado: (2021) -
Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial [Image: see text] ()
por: Huddart, Robert A., et al.
Publicado: (2020)